Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Avon Restructures In Europe, Latin America; Expected Savings Now $430 Mil.

This article was originally published in The Rose Sheet

Executive Summary

Avon is capping off its restructuring program with initiatives that will help the firm achieve annualized savings of $430 million by 2012, the firm announces January 8

You may also be interested in...



New Avon Literature Highlights Value-Oriented Products; Firm Ups Ad Spend

Avon is sharpening its "smart-value" product message globally in product brochures and other branded literature this year in order to appeal to customers on tight budgets, CEO Andrea Jung said during a Feb. 3 analyst call

New Avon Literature Highlights Value-Oriented Products; Firm Ups Ad Spend

Avon is sharpening its "smart-value" product message globally in product brochures and other branded literature this year in order to appeal to customers on tight budgets, CEO Andrea Jung said during a Feb. 3 analyst call

Avon Restructuring Program Paying Off In Q2

Avon's second-quarter sales and earnings performance signals that the company is realizing benefits of its three-year-old restructuring program while effectively offsetting high commodity costs, the firm indicated during a July 30 earnings call

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS015164

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel